APSR2026-372

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-033
P88
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1/b9981a25a13914e0583bb7d5e56eadc7.pdf
Format: PDF Only
06. Tuberculosis
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Andreas Haryono * Airlangga University Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Surabaya Indonesia Dr. Soetomo General Hospital Department of Pulmonology and Respiratory Medicine Surabaya Indonesia
Arief Bakhtiar - Airlangga University Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Surabaya Indonesia Dr. Soetomo General Hospital Department of Pulmonology and Respiratory Medicine Surabaya Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Andreas
Haryono
andreasharyono89@gmail.com
+6285252457781
31-40
Indonesia
Case Report
A case of recurrent gastrointestinal hemorrhage in concurrent Multiple Myeloma and Tuberculous Colitis
Maximum 25 words
Abstract Content
 
 
 
 
Multiple myeloma (MM) and tuberculosis (TB) are distinct diseases with complex interaction. Immune dysfunction in multiple myeloma increasing susceptibility to tuberculosis infection. Conversely, active tuberculosis infection complicating the management and worsen the prognosis of multiple myeloma. This case highlight the diagnostic and treatment challenge of concurrent MM and tuberculous colitis due to overlapping symptoms and immunosupressive nature of MM treatment.
This report details a 50-year-old male with recurrent melena and hematochezia. The patient experienced general weakness, dizziness, abdominal pain, worsening lower back pain, and unmeasured weight loss. Past medical history showed recurrent hospitalizations for gastrointestinal bleeding and anemia requiring transfusions. Initial colonoscopy showed non-specific chronic colitis, without improvement after 6 months of standard treatment. On current admission, severe anemia (2.9 g/dL), thrombocytopenia (34,000) and osteolytic bone lesions were noted. Blood monoclonal gammopathy and bone marrow aspiration confirmed MM (88% plasma cells). Both GeneXpert MTB/RIF test from feces and colon tissue biopsies confirmed tuberculous colitis. Endoscopy revealed erosive gastritis and active gastric ulcers with active bleeding, treated with adrenaline injection and hemoclips. Embolization of the ileocolic artery then performed to control gastric bleeding that reoccured. The patient then treated with four fixed dose combination (4FDC) anti-TB regiment and planned for MM treatment using bortezomib regiment.
This case illustrates the crucial interrelationship between hematologic malignancy and TB infection. Patient with MM have higher risk of contracting TB infection, while TB infection increased multiple myeloma mortality. Gastrointestinal TB infection intensifying the patient complications such as recurrent gastrointestinal bleeding and anemia. Furthermore, standard treatment of multiple myeloma by using bortezomib regiment in MM patient carries risk of further immunosuppresion, necessitating intensive monitoring and integrated anti TB therapy to manage the burden of dual disease.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Gastrointestinal hemorrhage, Tuberculous Colitis, Multiple myeloma
maximum 3 keywords and no abbreviations, separated by commas
none
284